Trial 4P-21-2


Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy

Type: Prevention
Phase: Phase II
Status: Open to Accrual
Treatments: Immunotherapy
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Mike Nguyen, M.D.
Other Trial Staff:  Aaron Mejia, Coordinator, Cheryl Kefauver, R.N., Monica Flores, D.M., Lagrimas Ilagan, D.M., Roberto Tejada, Coordinator, Honorina Enright, D.M., Amanda Luna, Coordinator, Ileana Aldana, Coordinator, Bartolo Santos, Coordinator, Aubrianne Cho, Coordinator, Thomas Elimihele, D.M., Viviana Moreno, D.M., Sarah Chevalier, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.